Lampiran 1
DAFTAR RIWAYAT HIDUP
Nama
: Desi Ratnasari Sarumpaet
Tempat, Tanggal Lahir
: Kotapinang, 17 Desember 1991
Alamat
: Jl. Kampung baru II No.62 Kotapinang
Agama
: Islam
JenisKelamin
: Perempuan
RiwayatPendidikan
:
1. Taman Kanak-KanakAl-wasliyah
1996 -1998
2. SD RGM Blok Songo
1998 - 2004
3. SMP Negeri 2 Kotapinang
2004 -2007
4. SMA Negeri 1 Rantau Selatan
2007- 2010
5. FakultasKedokteranUniversit as Sumatera Utara
2010-sekarang
RiwayatOrganisasi
:
1. Anggota Paskibraka
2002-2004
2. Anggota OSIS
2004-2005
Lampiran 4
Kode SPESIMEN TANGGAL ORGANISME AM AMC AN CAZ CIP CS CTX FEP GM IPM LEV MEM SXT TGC TM TZP
AM023 PUS 1/18/2012 Ps.aeruginosa R R R R R R R R R S R S R R R R
UJUNG DISTAS
NEKROTIK
AM060 SPUTUM 2/24/2012 Ps.aeruginosa R R R R R R R R
AM074 SPUTUM 3/6/2012 Ps.aeruginosa R R S S I S R S S S I S R R S S
AM088 URINE 3/19/2012 Ps.aeruginosa
AM100 PUS 3/29/2012 Ps.aeruginosa R R S I R S R I R R R R R R R S
AM120 URINE 4/11/2012 Ps.aeruginosa
AM121 SPUTUM 4/12/2012 Ps.aeruginosa R R R R R S R R R R R R R R R R
AM122 C.PLEURA 4/12/2012 Ps.aeruginosa
AM123 SWAB TELINGA 4/13/2012 Ps.aeruginosa R R S S S S R S S S S S R R S S
AM124 SWAB TELINGA 4/13/2012 Ps.aeruginosa R R S S S S R S S S S S R R S S
AM152 C.BAL 5/2/2012 Ps.aeruginosa R S S S S S I S S S S S S S I R
AM167 URINE 5/11/2012 Ps.aeruginosa
Kode Spesimen Tanggal Organisme AM AMC AN CAZ CIP CS CTX FEP GM IPM LEV MEM SAM SXT TGC TM TZP
AM009 URINE 7/7/2012 Ps.aeruginosa
AM010 PUS 7/11/2012 Ps.aeruginosa R R S S S S R S S S S S R R S S
SWAB TELINGA
KANAN 7/19/2012 Ps.aeruginosa R R S S S S R S S S S S R R S S
AM024 URINE 7/20/2012 Ps.aeruginosa R R S S S S R S S S S S R R S S
AM026 SPUTUM 7/21/2012 Ps.aeruginosa R R S S S S R S S S S S R R S S
AM034 CAIRAN 8/2/2012 Ps.aeruginosa
AM035 CAIRAN 8/2/2012 Ps.aeruginosa R R R R R R R R R I R R R R R R
AM036 NANAH 8/2/2012 Ps.aeruginosa
AM037 NANAH 8/2/2012 Ps.aeruginosa R R S I R S R I R R R R R R R S
AM038 SPUTUM 8/2/2012 Ps.aeruginosa
AM039 SPUTUM 8/2/2012 Ps.aeruginosa R R S S S S R S S S S S R R S S
AM040 CAIRAN 8/2/2012 Ps.aeruginosa
AM041 CAIRAN 8/2/2012 Ps.aeruginosa R R S S S R R S I S S S R R R S
SEKRET DAN
AM052 CAIRAN 8/11/2012 Ps.aeruginosa R R S S S S R S R S S S R R R S
AM053 NANAH 8/11/2012 Ps.aeruginosa R R R R R S R R R S R S R R R R
AM054 CAIRAN 8/13/2012 Ps.aeruginosa R R S S R S R S S S R S R R S S
AM055 CAIRAN 8/15/2012 Ps.aeruginosa R R S S S R R S R S S S R R R S
AM056
SEKRET DAN
HAPUSAN 8/16/2012 Ps.aeruginosa R R S S R S R S R S R S R R S R
AM057
SEKRET DAN
HAPUSAN 8/16/2012 Ps.aeruginosa R R S R R S R R R I R I R R R R
SEKRET DAN
HAPUSAN 8/24/2012 Ps.aeruginosa R R S S S S R S S S S S R R S S
AM063 SPUTUM 8/25/2012 Ps.aeruginosa R R S S S S R S S S S S R R S S
AM064 NANAH 8/29/2012 Ps.aeruginosa R R R R R S R R R S R S R R R R
AM065
SEKRET DAN
AM077 DARAH 9/11/2012 Ps.aeruginosa S S S S S S S S R S S S S S S S
AM078 NANAH 9/12/2012 Ps.aeruginosa R R S S S S R S S S S S R R S S
AM079 NANAH 9/12/2012 Ps.aeruginosa R R S S S S R S S S S S R R S S
AM080
SEKRET DAN
HAPUSAN 9/12/2012 Ps.aeruginosa R R R R R S R R R S R S R R R R
SEKRET DAN
HAPUSAN 9/18/2012 Ps.aeruginosa R R R R R S R R R S R S R R R R
SEKRET DAN
HAPUSAN 9/24/2012 Ps.aeruginosa R R S S S S R S S S S S R R S S
AM100 LAIN-LAIN 9/24/2012 Ps.aeruginosa R R R R R S R R R R R R R R R R
AM102 SPUTUM 9/25/2012 Ps.aeruginosa R R R R R S R R R S R S R R R R
AM113 LAIN-LAIN 10/1/2012 Ps.aeruginosa S S S S S R
AM114 NANAH 10/1/2012 Ps.aeruginosa R R R R R R R S R R R R
AM154 NANAH 11/1/2012 Ps.aeruginosa R R R R R R R I R R R R
SEKRET DAN
HAPUSAN 11/20/2012 Ps.aeruginosa R S S S S S S S R R R
AM176 SPUTUM 11/20/2012 Ps.aeruginosa R S S S S S S S R R R S
AM177 LAIN-LAIN 11/21/2012 Ps.aeruginosa R S S S S S I S R R R S
AM178 SPUTUM 11/21/2012 Ps.aeruginosa R R R R R R R S R R R R
AM180 CAIRAN BAL 11/21/2012 Ps.aeruginosa R S S S S S S S R R R S
SEKRET DAN
HAPUSAN 11/29/2012 Ps.aeruginosa R S S S S S S S R R R S
AM193
SEKRET DAN
HAPUSAN 11/29/2012 Ps.aeruginosa R S S R S S I S R R R S
AM194 CAIRAN BAL 11/30/2012 Ps.aeruginosa R I R R R R R R R R R R
AM195 LAIN-LAIN 12/1/2012 Ps.aeruginosa R S S S S S S S R R R S
AM196 SPUTUM 12/1/2012 Ps.aeruginosa R S S I I I I S R R R S
i
Keterangan :
R = Resisten
FEP =Sefepim
I = Intermediet
GM =Gentamisin
S = Sensitif
IPM =Imipenem
AM = Ampisilin
LEV =Levofloksasin
MEM = Meropenem
AMC = Amoksisilin Clavulanic acid
AN = Amikasin
SAM = Ampisilin Sulbaktam
CAZ = Seftazidim
SXT = Trimethoprim Sufametoksazol
CIP = siprofoksasin
TGC = Tigesiklin
CS = Kolistin
TM = Tobramisin
ii
Output periode 1
Ampisilin
Frequency Percent Valid Percent
Cumulative
Total 229 100.0 100.0
Amoksisilin Clavulanic acid
Frequency Percent Valid Percent
Cumulative
Total 229 100.0 100.0
Amikasin
Frequency Percent Valid Percent
Cumulative
Total 229 100.0 100.0
Seftazidim
Frequency Percent Valid Percent
Cumulative
iii
Siprofloksasin
Frequency Percent Valid Percent
Cumulative
Total 229 100.0 100.0
Kolistin
Frequency Percent Valid Percent
Cumulative
Percent
Valid 6 2.6 2.6 2.6
R 76 33.2 33.2 35.8
S 147 64.2 64.2 100.0
Total 229 100.0 100.0
Sefotaksim
Frequency Percent Valid Percent
Cumulative
Total 229 100.0 100.0
Sefepim
Frequency Percent Valid Percent
Cumulative
Total 229 100.0 100.0
iv
Frequency Percent Valid Percent
Cumulative
Total 229 100.0 100.0
Imipenem
Frequency Percent Valid Percent
Cumulative
Total 229 100.0 100.0
Levoproksasin
Frequency Percent Valid Percent
Cumulative
Total 229 100.0 100.0
Meropenem
Frequency Percent Valid Percent
Cumulative
Total 229 100.0 100.0
Trimethoprim Sulfametoksazol
Frequency Percent Valid Percent
Cumulative
v
Valid 5 2.2 2.2 2.2
R 219 95.6 95.6 97.8
S 5 2.2 2.2 100.0
Total 229 100.0 100.0
Tigesiklin
Frequency Percent Valid Percent
Cumulative
Percent
Valid 6 2.6 2.6 2.6
R 214 93.4 93.4 96.1
S 9 3.9 3.9 100.0
Total 229 100.0 100.0
Tobramisin
Frequency Percent Valid Percent
Cumulative
Total 229 100.0 100.0
Piperasilin/Tazobaktam
Frequency Percent Valid Percent
Cumulative
Percent
Valid 7 3.1 3.1 3.1
R 72 31.4 31.4 34.5
S 150 65.5 65.5 100.0
vi
Output periode 2
Ampisilin
Frequency Percent Valid Percent
Cumulative
Percent
Valid 8 4.1 4.1 4.1
R 189 95.9 95.9 100.0
Total 197 100.0 100.0
Amoksisilin Clavulanic acid
Frequency Percent Valid Percent
Cumulative
Percent
Valid 84 42.6 42.6 42.6
R 111 56.3 56.3 99.0
S 2 1.0 1.0 100.0
Total 197 100.0 100.0
Amikasin
Frequency Percent Valid Percent
Cumulative
Total 197 100.0 100.0
Seftazidim
Frequency Percent Valid Percent
Cumulative
Total 197 100.0 100.0
Siprofloksasin
Frequency Percent Valid Percent
Cumulative
vii
Valid 7 3.6 3.6 3.6
I 9 4.6 4.6 8.1
R 78 39.6 39.6 47.7
S 103 52.3 52.3 100.0
Total 197 100.0 100.0
Kolistin
Frequency Percent Valid Percent
Cumulative
Percent
Valid 84 42.6 42.6 42.6
R 13 6.6 6.6 49.2
S 100 50.8 50.8 100.0
Total 197 100.0 100.0
Sefotaksim
Frequency Percent Valid Percent
Cumulative
Percent
Valid 85 43.1 43.1 43.1
I 2 1.0 1.0 44.2
R 109 55.3 55.3 99.5
S 1 .5 .5 100.0
Total 197 100.0 100.0
Sefepim
Frequency Percent Valid Percent
Cumulative
Total 197 100.0 100.0
Gentamisin
Frequency Percent Valid Percent
Cumulative
Percent
Valid 8 4.1 4.1 4.1
viii
R 88 44.7 44.7 51.3
S 96 48.7 48.7 100.0
Total 197 100.0 100.0
Imipenem
Frequency Percent Valid Percent
Cumulative
Percent
Valid 84 42.6 42.6 42.6
I 6 3.0 3.0 45.7
R 12 6.1 6.1 51.8
S 95 48.2 48.2 100.0
Total 197 100.0 100.0
Levoproksasin
Frequency Percent Valid Percent
Cumulative
Total 197 100.0 100.0
Trimethoprim Sulfametoksazol
Frequency Percent Valid Percent
Cumulative
Percent
Valid 9 4.6 4.6 4.6
R 184 93.4 93.4 98.0
S 4 2.0 2.0 100.0
Total 197 100.0 100.0
Tigesiklin
Frequency Percent Valid Percent
Cumulative
Percent
Valid 9 4.6 4.6 4.6
R 184 93.4 93.4 98.0
S 4 2.0 2.0 100.0
ix
Tobramisin
Frequency Percent Valid Percent
Cumulative
Percent
Valid 84 42.6 42.6 42.6
I 2 1.0 1.0 43.7
R 47 23.9 23.9 67.5
S 64 32.5 32.5 100.0
Total 197 100.0 100.0
Piperasilin/Tazobaktam
Frequency Percent Valid Percent
Cumulative
Percent
Valid 9 4.6 4.6 4.6
R 58 29.4 29.4 34.0
S 130 66.0 66.0 100.0
Total 197 100.0 100.0
Nama spesimen periode 1
Nama Spesimen
Frequency Percent Valid Percent
Cumulative
Percent
Valid BAL 3 1.3 1.3 1.3
C.BAL 15 6.6 6.6 7.9
C.KISTA BORTOLIN 1 .4 .4 8.3
C.OTAK 4 1.7 1.7 10.0
C.PLEURA 13 5.7 5.7 15.7
C.SACSION 1 .4 .4 16.2
JARINGAN NEKROTIK 1 .4 .4 20.5
PUS 47 20.5 20.5 41.0
S.TELINGA KIRI 1 .4 .4 41.5
SEKRET 2 .9 .9 42.4
x
SELANG EVD 1 .4 .4 44.1
SPUTUM 92 40.2 40.2 84.3
SWAB 15 6.6 6.6 90.8
SWAB TELINGA 3 1.3 1.3 92.1
TINJA 1 .4 .4 92.6
UJUNG DISTAS SELANG 1 .4 .4 93.0
UJUNG ETT 2 .9 .9 93.9
URINE 14 6.1 6.1 100.0
Total 229 100.0 100.0
Periode 2
Nama Spesimen
Frequency Percent Valid Percent
Cumulative
Percent
Valid C.BAL 6 3.0 3.0 3.0
CAIRAN 21 10.7 10.7 13.7
CAIRAN BAL 14 7.1 7.1 20.8
CAIRAN PLEURA 1 .5 .5 21.3
DARAH 6 3.0 3.0 24.4
JARINGAN 1 .5 .5 24.9
LAIN-LAIN 12 6.1 6.1 31.0
NANAH 35 17.8 17.8 48.7
PUS 8 4.1 4.1 52.8
SEKRET 1 .5 .5 53.3
SEKRET DAN HAPUSAN 11 5.6 5.6 58.9
SPUTUM 59 29.9 29.9 88.8
SWAB 10 5.1 5.1 93.9
SWAB TELINGA KANAN 1 .5 .5 94.4
UJUNG ETT 1 .5 .5 94.9
UJUNG KATETER 1 .5 .5 95.4
URINE 9 4.6 4.6 100.0
xi
Crosstabs
[DataSet2] C:\Users\RIZKA\Documents\SPSS REVISI 2.sav
Case Processing Summary
Cases
Valid Missing Total
N Percent N Percent N Percent
Kolistin * Kolistin2 222 100.0% 0 .0% 222 100.0%
Kolistin * Kolistin2 Crosstabulation
Kolistin2
Total
R S
Kolistin R Count 25 5 46 76
Expected Count 37.7 4.5 33.9 76.0
% within Kolistin2 22.7% 38.5% 46.5% 34.2%
S Count 85 8 53 146
Expected Count 72.3 8.5 65.1 146.0
% within Kolistin2 77.3% 61.5% 53.5% 65.8%
Total Count 110 13 99 222
Expected Count 110.0 13.0 99.0 222.0
% within Kolistin2 100.0% 100.0% 100.0% 100.0%
Chi-Square Tests
Value df Asymp. Sig. (2-sided)
Pearson Chi-Square 13.150a 2 .001
Likelihood Ratio 13.322 2 .001
N of Valid Cases 222
xii
Crosstabs
[DataSet2] C:\Users\RIZKA\Documents\SPSS REVISI 2.sav
Case Processing Summary
Cases
Valid Missing Total
N Percent N Percent N Percent
Imipenem * Imipenem2 222 100.0% 0 .0% 222 100.0%
Imipenem * Imipenem2 Crosstabulation
Imipenem2
Total
I R S
Imipenem I Count 10 0 2 7 19
Expected Count 9.4 .5 .9 8.1 19.0
% within Imipenem2 9.1% .0% 18.2% 7.4% 8.6%
R Count 11 5 2 16 34
Expected Count 16.8 .9 1.7 14.5 34.0
% within Imipenem2 10.0% 83.3% 18.2% 16.8% 15.3%
S Count 89 1 7 72 169
Expected Count 83.7 4.6 8.4 72.3 169.0
% within Imipenem2 80.9% 16.7% 63.6% 75.8% 76.1%
Total Count 110 6 11 95 222
Expected Count 110.0 6.0 11.0 95.0 222.0
% within Imipenem2 100.0% 100.0% 100.0% 100.0% 100.0%
Chi-Square Tests
Value df Asymp. Sig. (2-sided)
Pearson Chi-Square 25.599a 6 .000
Likelihood Ratio 18.075 6 .006
N of Valid Cases 222
